Lonza

lonza.com · Basel, Switzerland

Lonza is a global contract development and manufacturing organization that provides services and technologies for the pharmaceutical, biotech, and nutrition industries, including custom development and large-scale production of active ingredients and finished dosage forms. The company serves biotech startups, large pharma, and consumer health companies by offering outsourced R&D, manufacturing, and related support services. It generates revenue through long-term manufacturing contracts, development services, and licensing of proprietary technologies.

Revenue
$1B+
Employees
5,001+
Founded
1897
Headquarters
Basel, Switzerland

Lonza customers on Arbolus

Total customers 71 68 current · 3 former
Reviews growth 24 new reviews since Jun 2026

Customers who reviewed Lonza

Seniority of Lonza customers

The largest group of people who reviewed Lonza holds C-Suite roles (43%), followed by Director (40%) and Manager (17%).

  • C-Suite 43%
  • Director 40%
  • Manager 17%

Customers sample

Operations Leader C-Suite NPS 9 Will renew
People Leader Director NPS 6 Undecided
Product Leader Manager NPS 9 Will renew

Employer names and spend open in the full report, along with the other 68 customers.

What 71 Arbolus experts think of Lonza

Overall sentiment: Positive

NPS distribution shows 45.7% Promoters, 35.7% Passives, and 18.6% Detractors, with an average NPS of 7.99 and a score of 27.1. Renewal intent is positive, with 53.8% likely to renew, 7.7% unlikely, and 38.5% unsure. Stickiness is high, with 70% of customers using Lonza for more than one year. Key feedback themes highlight strong manufacturing quality and regulatory expertise, but concerns about cost and scheduling rigidity persist.

Everything 71 customers told us about Lonza.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Sentiment

26 Net Promoter Score, from 71 scored reviews
  • Promoters 32
  • Passives 26
  • Detractors 13

Praised

  • Manufacturing Quality and Regulatory Expertise
  • AI-Driven Process Optimization

Criticised

  • Premium Pricing and Rigid Scheduling
  • Agile Competitors and Commoditization Risk

What Lonza customers say

Manufacturing Quality and Regulatory Expertise

“I gave Lonza a 6 because their manufacturing quality and regulatory track record are virtually bulletproof, which is exactly what you want when scaling complex therapeutics.”

Other Generalist · Health Care · 1,001 to 5,000 employees · North America

AI-Driven Process Optimization

“If an enterprise AI platform becomes capable of perfectly predicting scale-up parameters and optimizing cell line expression virtually, we could bypass Lonza's expensive developmental services entirely.”

Other Generalist · Health Care · 1,001 to 5,000 employees · North America

Premium Pricing and Rigid Scheduling

“It misses a 9 or 10 solely because of the steep premium pricing and the rigid, long-lead-time scheduling required to secure a manufacturing slot.”

Other Generalist · Health Care · 1,001 to 5,000 employees · North America

Renewal intent

Plan to renew 57%
  • Will renew 23
  • Undecided 14
  • Not renewing 3

Plan to renew, by seniority

  • C-Suite 47% 15 answers
  • Director 68% 19 answers
  • Manager 60% 5 answers
  • Not specified 0% 1 answer
  • 8.4/10 Average score from customers who will renew
  • 7.6/10 Average score from undecided customers
  • 7.3/10 Average score from customers not renewing

Top alternatives

Most weighed by Lonza customers

Report

Nov 2026 71 + 1

For people who use Lonza

Do you use Lonza at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 71 customers of Lonza have already contributed

Takes a few minutes. Your identity stays anonymous.